title: Age, cell signalling and cardioprotection.
abstract: For many years investigators have been researching methods of preconditioning the myocardium against ischaemia-induced damage; however, a majority of this research has been carried out in young animals and cells. Normal ageing is accompanied by changes in the human myocardium that decrease its capacity to tolerate and respond to various forms of stress. Also, the likelihood of experiencing an ischaemic stress and other cardiovascular complications increases as an individual ages; therefore, an aged population would benefit most from cardioprotective treatments. Methods currently known to provide cardioprotection (or preconditioning) include exercise, heat stress, oxidative stress, brief ischaemia, stretch and certain pharmacological interventions. It is unclear whether the aged myocardium can adapt to a preconditioning stimulus; however, many researchers have observed age-related alterations in the expression and activation of proteins key to the cardioprotective process. These proteins include heat shock protein 70 (HSP70), nitric oxide synthase (NOS), the sodium-hydrogen exchanger (NHE), and the mitogen-activated protein (MAP) kinases c-Jun N-terminal Kinase (JNK), extracellular signal-regulated kinase (ERK), and p38. Therefore, the purpose of the current review will be to outline the current knowledge of these cardioprotective agents in an aged myocardium. Interactions among the cardioprotective agents outlined herein suggest that age-related changes in the myocardium will need to be better understood before cardioprotective interventions that have been proved effective in young animals can be applied to an aged human population.
authors.affiliation: Department of Kinesiology, University of Texas, Austin, TX 78712, USA.
authors.forename: R P
authors.initials: RP
authors.lastname: Taylor
authors.forename: J W
authors.initials: JW
authors.lastname: Starnes
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000502:physiology*; D000818:Animals; D002316:Cardiotonic Agents / Q000378:metabolism; D004347:Drug Interactions / Q000502:physiology; D018840:HSP70 Heat-Shock Proteins / Q000378:metabolism; D006331:Heart Diseases / Q000503:physiopathology / Q000517:prevention & control*; D006801:Humans; D019157:Ischemic Preconditioning, Myocardial / Q000379:methods*; D008875:Middle Aged; D020928:Mitogen-Activated Protein Kinases / Q000378:metabolism; D008954:Models, Biological; D009206:Myocardium / Q000378:metabolism*; D019001:Nitric Oxide Synthase / Q000378:metabolism; D051381:Rats; D015398:Signal Transduction; D017923:Sodium-Hydrogen Exchangers / Q000378:metabolism
chemical_list: D002316:Cardiotonic Agents; D018840:HSP70 Heat-Shock Proteins; D017923:Sodium-Hydrogen Exchangers; D019001:Nitric Oxide Synthase; D020928:Mitogen-Activated Protein Kinases